ENDOG and B-cell chronic lymphocytic leukemia: ENDOG expression levels were associated with the evolution of M-CLL with a median TTT of 7.23 years versus 13.61 years for patients with high and low ENDOG expression, respectively (p = 0.0033) (Figure 5a) (Table S1a).